Atlas Trials

Patients With Relapse Remitting Multiple Sclerosis (RRMS): Candidates for MS Therapy Change

Clinical trial NCT01317004 · COMPLETED

Trial details

NCT number
NCT01317004
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Relapsing Remitting Multiple Sclerosis
Start date
2011-05-01
Primary completion
2014-06-01
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.